The Valley Desk

NCT01576666 · Interventional trial

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Overall registry status Completed

Phase 1

Conditions Advanced Pancreatic Adenocarcinoma, Advanced Solid Tumors, Dose Escalation, Gastric Cancer, Gastroesophageal Junction Cancer, Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Preliminary Efficacy, Recurrent Glioblastoma Multiforme, Safety, Triple Negative Metastatic Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov